[Biomarkers in the treatment of retinal vein occlusion].
Biomarker in der Therapie venöser retinaler Gefäßverschlüsse.
Branch vein occlusion
Central vein occlusion
Optical coherence tomography
Retinal vein occlusion
Ultra-widefield fluorescein angiography
Journal
Die Ophthalmologie
ISSN: 2731-7218
Titre abrégé: Ophthalmologie
Pays: Germany
ID NLM: 9918402288106676
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
accepted:
29
08
2022
pubmed:
7
10
2022
medline:
19
11
2022
entrez:
6
10
2022
Statut:
ppublish
Résumé
Retinal vein occlusion, subdivided into central retinal and branch retinal vein occlusion, is one of the most frequent vascular diseases of the retina. Biomarkers of optical coherence tomography (OCT), OCT-angiography and (ultra-widefield) fluorescein angiography are of exceptional importance in the initial diagnosis and also in the treatment of complications associated with retinal vascular occlusion, particularly macular edema. A systematic literature review was carried out in PubMed with the keywords central retinal vein occlusion, branch retinal vein occlusion, biomarker, OCT, OCT angiography, ultra-widefield fluorescein angiography with prioritization of the most important aspects. Relevant biomarkers in OCT include central retinal thickness (CRT), macular fluid, the integrity of the photoreceptor bands (external limiting membrane and ellipsoid zone), disorganization of retinal inner layers (DRIL), hyperreflective foci, choroidal thickness and signs of ischemia, such as a prominent middle limiting membrane (p-MLM), paracentral acute middle maculopathy (PAMM) as well as hyperreflectivity of inner retinal layers (HIRL). The importance of OCT-angiography lies particularly in the assessment of microvascular alterations, especially vessel density in the deep retinal vascular plexus, the foveal avascular zone and of areas with no capillary perfusion. Biomarkers of ultra-widefield angiography, such as peripheral ischemia (ischemic index) and neovascularízation are essential with respect to treatment decisions for retinal laser. A multitude of simple and complex biomarkers currently enable an effective individualized evaluation of treatment and prognosis in retinal vein occlusion. A shift from invasive to noninvasive biomarkers can be observed. HINTERGRUND: Retinale Venenverschlüsse, subsumiert in Zentralvenen- und Venenastverschluss, gehören zu den häufigsten vaskulären Erkrankungen der Netzhaut. Sowohl bei Erstdiagnose als auch in der Therapie verschlussassoziierter Komplikationen, v. a. des Makulaödems, sind Biomarker der optischen Kohärenztomographie (OCT), OCT-Angiographie und (Ultraweitwinkel‑)Fluoreszeinangiographie von herausragender Bedeutung. Es erfolgte eine systematische Literaturrecherche auf pubmed.gov mit den Keywords „central retinal vein occlusion“, „branch retinal vein occlusion“, „biomarker“, „OCT“, „OCT angiography“, „ultra-widefield fluorescein angiography“ mit Priorisierung der wichtigsten Aspekte zur Umfangsreduktion. Als relevante Biomarker konnten in der OCT Makuladicke („central retinal thickness“ [CRT]), makuläre Flüssigkeit, die Integrität der Photorezeptorbande (Membrana limitans externa [ELM] und „ellipsoid zone“ [EZ]), „disorganization of retinal inner layers“ (DRIL), hyperreflektive Foci, Aderhautdicke sowie Ischämiezeichen wie „prominent middle limiting membrane“ (p-MLM), die „paracentral acute middle maculopathy“ (PAMM) sowie „hyperreflectivity of inner retinal layers“ (HIRL) identifiziert werden. Der Stellenwert der OCT-Angiographie liegt v. a. in der Beurteilung mikrovaskulärer Veränderungen, insbesondere der „vessel density“ im tiefen retinalen Gefäßplexus, der fovealen avaskulären Zone und von Arealen ohne Kapillarperfusion. Bezüglich der Therapieentscheidung zum Netzhautlaser sind Biomarker der Ultraweitwinkelangiographie wie periphere Ischämien („ischemic index“) sowie Neovaskularisationen essenziell. Eine Vielzahl simplerer und komplexer Biomarker ermöglicht heute eine effektive individualisierte Therapie- und Prognoseeinschätzung beim retinalen Venenverschluss. Eine Verschiebung von invasiven zu nichtinvasiven Biomarkern wird beobachtet.
Sections du résumé
BACKGROUND
BACKGROUND
Retinal vein occlusion, subdivided into central retinal and branch retinal vein occlusion, is one of the most frequent vascular diseases of the retina. Biomarkers of optical coherence tomography (OCT), OCT-angiography and (ultra-widefield) fluorescein angiography are of exceptional importance in the initial diagnosis and also in the treatment of complications associated with retinal vascular occlusion, particularly macular edema.
METHODS
METHODS
A systematic literature review was carried out in PubMed with the keywords central retinal vein occlusion, branch retinal vein occlusion, biomarker, OCT, OCT angiography, ultra-widefield fluorescein angiography with prioritization of the most important aspects.
RESULTS
RESULTS
Relevant biomarkers in OCT include central retinal thickness (CRT), macular fluid, the integrity of the photoreceptor bands (external limiting membrane and ellipsoid zone), disorganization of retinal inner layers (DRIL), hyperreflective foci, choroidal thickness and signs of ischemia, such as a prominent middle limiting membrane (p-MLM), paracentral acute middle maculopathy (PAMM) as well as hyperreflectivity of inner retinal layers (HIRL). The importance of OCT-angiography lies particularly in the assessment of microvascular alterations, especially vessel density in the deep retinal vascular plexus, the foveal avascular zone and of areas with no capillary perfusion. Biomarkers of ultra-widefield angiography, such as peripheral ischemia (ischemic index) and neovascularízation are essential with respect to treatment decisions for retinal laser.
CONCLUSION
CONCLUSIONS
A multitude of simple and complex biomarkers currently enable an effective individualized evaluation of treatment and prognosis in retinal vein occlusion. A shift from invasive to noninvasive biomarkers can be observed.
ZUSAMMENFASSUNG
UNASSIGNED
HINTERGRUND: Retinale Venenverschlüsse, subsumiert in Zentralvenen- und Venenastverschluss, gehören zu den häufigsten vaskulären Erkrankungen der Netzhaut. Sowohl bei Erstdiagnose als auch in der Therapie verschlussassoziierter Komplikationen, v. a. des Makulaödems, sind Biomarker der optischen Kohärenztomographie (OCT), OCT-Angiographie und (Ultraweitwinkel‑)Fluoreszeinangiographie von herausragender Bedeutung.
METHODEN
METHODS
Es erfolgte eine systematische Literaturrecherche auf pubmed.gov mit den Keywords „central retinal vein occlusion“, „branch retinal vein occlusion“, „biomarker“, „OCT“, „OCT angiography“, „ultra-widefield fluorescein angiography“ mit Priorisierung der wichtigsten Aspekte zur Umfangsreduktion.
ERGEBNISSE
UNASSIGNED
Als relevante Biomarker konnten in der OCT Makuladicke („central retinal thickness“ [CRT]), makuläre Flüssigkeit, die Integrität der Photorezeptorbande (Membrana limitans externa [ELM] und „ellipsoid zone“ [EZ]), „disorganization of retinal inner layers“ (DRIL), hyperreflektive Foci, Aderhautdicke sowie Ischämiezeichen wie „prominent middle limiting membrane“ (p-MLM), die „paracentral acute middle maculopathy“ (PAMM) sowie „hyperreflectivity of inner retinal layers“ (HIRL) identifiziert werden. Der Stellenwert der OCT-Angiographie liegt v. a. in der Beurteilung mikrovaskulärer Veränderungen, insbesondere der „vessel density“ im tiefen retinalen Gefäßplexus, der fovealen avaskulären Zone und von Arealen ohne Kapillarperfusion. Bezüglich der Therapieentscheidung zum Netzhautlaser sind Biomarker der Ultraweitwinkelangiographie wie periphere Ischämien („ischemic index“) sowie Neovaskularisationen essenziell.
SCHLUSSFOLGERUNG
UNASSIGNED
Eine Vielzahl simplerer und komplexer Biomarker ermöglicht heute eine effektive individualisierte Therapie- und Prognoseeinschätzung beim retinalen Venenverschluss. Eine Verschiebung von invasiven zu nichtinvasiven Biomarkern wird beobachtet.
Autres résumés
Type: Publisher
(ger)
HINTERGRUND: Retinale Venenverschlüsse, subsumiert in Zentralvenen- und Venenastverschluss, gehören zu den häufigsten vaskulären Erkrankungen der Netzhaut. Sowohl bei Erstdiagnose als auch in der Therapie verschlussassoziierter Komplikationen, v. a. des Makulaödems, sind Biomarker der optischen Kohärenztomographie (OCT), OCT-Angiographie und (Ultraweitwinkel‑)Fluoreszeinangiographie von herausragender Bedeutung.
Identifiants
pubmed: 36201041
doi: 10.1007/s00347-022-01732-1
pii: 10.1007/s00347-022-01732-1
doi:
Substances chimiques
Biomarkers
0
Types de publication
English Abstract
Journal Article
Review
Langues
ger
Sous-ensembles de citation
IM
Pagination
1111-1120Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
Références
Rogers S et al (2010) The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 117:313–319.e1. https://doi.org/10.1016/j.ophtha.2009.07.017
doi: 10.1016/j.ophtha.2009.07.017
pubmed: 20022117
Schmidt-Erfurth U et al (2019) Guidelines for the management of retinal vein occlusion by the European society of retina specialists (EURETINA). Ophthalmologica 242:123–162. https://doi.org/10.1159/000502041
doi: 10.1159/000502041
pubmed: 31412332
Ach T, Hoeh AE, Schaal KB, Scheuerle AF, Dithmar S (2010) Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 248:155–159. https://doi.org/10.1007/s00417-009-1167-6
doi: 10.1007/s00417-009-1167-6
pubmed: 19763601
Scott IU et al (2009) SCORE study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion. Ophthalmology 116:504–512. https://doi.org/10.1016/j.ophtha.2008.10.017
doi: 10.1016/j.ophtha.2008.10.017
pubmed: 19167078
Michl M et al (2021) The impact of structural optical coherence tomography changes on visual function in retinal vein occlusion. Acta Ophthalmol 99:418–426. https://doi.org/10.1111/aos.14621
doi: 10.1111/aos.14621
pubmed: 32996711
Casalino G, Williams M, McAvoy C, Bandello F, Chakravarthy U (2016) Optical coherence tomography angiography in paracentral acute middle maculopathy secondary to central retinal vein occlusion. Eye (Lond) 30:888–893. https://doi.org/10.1038/eye.2016.57
doi: 10.1038/eye.2016.57
Maltsev DS, Kulikov AN, Burnasheva MA, Chhablani J (2020) Prevalence of resolved paracentral acute middle maculopathy lesions in fellow eyes of patients with unilateral retinal vein occlusion. Acta Ophthalmol 98:e22–e28. https://doi.org/10.1111/aos.14196
doi: 10.1111/aos.14196
pubmed: 31347293
Bakhoum MF et al (2018) Paracentral acute middle maculopathy and the ischemic cascade associated with retinal vascular occlusion. Am J Ophthalmol 195:143–153. https://doi.org/10.1016/j.ajo.2018.07.031
doi: 10.1016/j.ajo.2018.07.031
pubmed: 30081014
Browning DJ, Punjabi OS, Lee C (2017) Assessment of ischemia in acute central retinal vein occlusion from inner retinal reflectivity on spectral domain optical coherence tomography. Clin Ophthalmol 11:71–79. https://doi.org/10.2147/opth.S122683
doi: 10.2147/opth.S122683
pubmed: 28053503
Kitagawa S et al (2018) Better prognosis for eyes with preserved foveal depression after Intravitreal ranibizumab injection for macular edema secondary to central retinal vein occlusion. Retina 38:1354–1360. https://doi.org/10.1097/iae.0000000000001707
doi: 10.1097/iae.0000000000001707
pubmed: 28538263
Tang F et al (2020) Optical coherence tomography predictors of short-term visual acuity in eyes with macular edema secondary to retinal vein occlusion treated with intravitreal conbercept. Retina 40:773–785. https://doi.org/10.1097/iae.0000000000002444
doi: 10.1097/iae.0000000000002444
pubmed: 30640282
Gurudas S et al (2022) Visual outcomes associated with patterns of macular edema resolution in central retinal vein occlusion treated with anti-vascular endothelial growth factor therapy: a post hoc analysis of the Lucentis, Eylea, Avastin in vein occlusion (LEAVO) trial. JAMA Ophthalmol. https://doi.org/10.1001/jamaophthalmol.2021.5619
doi: 10.1001/jamaophthalmol.2021.5619
pubmed: 35511139
pmcid: 9073659
Yiu G et al (2020) Spectral-domain OCT predictors of visual outcomes after ranibizumab treatment for macular edema resulting from retinal vein occlusion. Ophthalmol Retina 4:67–76. https://doi.org/10.1016/j.oret.2019.08.009
doi: 10.1016/j.oret.2019.08.009
pubmed: 31669329
Bhisitkul RB, Campochiaro PA, Shapiro H, Rubio RG (2013) Predictive value in retinal vein occlusions of early versus late or incomplete ranibizumab response defined by optical coherence tomography. Ophthalmology 120:1057–1063. https://doi.org/10.1016/j.ophtha.2012.11.011
doi: 10.1016/j.ophtha.2012.11.011
pubmed: 23415775
Etheridge T et al (2021) Spectral domain OCT predictors of visual acuity in the study of comparative treatments for retinal vein occlusion 2: SCORE 2 report 15. Ophthalmol Retina 5:991–998. https://doi.org/10.1016/j.oret.2020.12.016
doi: 10.1016/j.oret.2020.12.016
pubmed: 33373715
Fragiotta S et al (2021) Significance of hyperreflective foci as an optical coherence tomography biomarker in retinal diseases: characterization and clinical implications. J Ophthalmol. https://doi.org/10.1155/2021/6096017
doi: 10.1155/2021/6096017
pubmed: 34956669
pmcid: 8709761
Bolz M et al (2009) Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology 116:914–920. https://doi.org/10.1016/j.ophtha.2008.12.039
doi: 10.1016/j.ophtha.2008.12.039
pubmed: 19410950
Kang JW, Lee H, Chung H, Kim HC (2014) Correlation between optical coherence tomographic hyperreflective foci and visual outcomes after intravitreal bevacizumab for macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 252:1413–1421. https://doi.org/10.1007/s00417-014-2595-5
doi: 10.1007/s00417-014-2595-5
pubmed: 24577742
Mo B, Zhou HY, Jiao X, Zhang F (2017) Evaluation of hyperreflective foci as a prognostic factor of visual outcome in retinal vein occlusion. Int J Ophthalmol 10:605–612. https://doi.org/10.18240/ijo.2017.04.17
doi: 10.18240/ijo.2017.04.17
pubmed: 28503435
pmcid: 5406640
Chatziralli IP, Sergentanis TN, Sivaprasad S (2016) Hyperreflective foci as an independent visual outcome predictor in macular edema due to retinal vascular diseases treated with intravitreal dexamethasone or ranibizumab. Retina 36:2319–2328. https://doi.org/10.1097/iae.0000000000001070
doi: 10.1097/iae.0000000000001070
pubmed: 27258668
Hwang HS, Chae JB, Kim JY, Kim DY (2017) Association between hyperreflective dots on spectral-domain optical coherence tomography in macular edema and response to treatment. Invest Ophthalmol Vis Sci 58:5958–5967. https://doi.org/10.1167/iovs.17-22725
doi: 10.1167/iovs.17-22725
pubmed: 29183041
Sun JK et al (2014) Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema. JAMA Ophthalmol 132:1309–1316. https://doi.org/10.1001/jamaophthalmol.2014.2350
doi: 10.1001/jamaophthalmol.2014.2350
pubmed: 25058813
Babiuch AS et al (2019) Association of disorganization of retinal inner layers with visual acuity response to anti-vascular endothelial growth factor therapy for macular edema secondary to retinal vein occlusion. JAMA Ophthalmol 137:38–46. https://doi.org/10.1001/jamaophthalmol.2018.4484
doi: 10.1001/jamaophthalmol.2018.4484
pubmed: 30286219
Kanai M et al (2021) Association of disorganization of retinal inner layers with optical coherence tomography angiography features in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 259:2897–2903. https://doi.org/10.1007/s00417-021-05168-2
doi: 10.1007/s00417-021-05168-2
pubmed: 33861366
Chu YK, Hong YT, Byeon SH, Kwon OW (2013) In vivo detection of acute ischemic damages in retinal arterial occlusion with optical coherence tomography: a “prominent middle limiting membrane sign”. Retina 33:2110–2117. https://doi.org/10.1097/IAE.0b013e3182899205
doi: 10.1097/IAE.0b013e3182899205
pubmed: 23594722
Furashova O, Matthè E (2020) Hyperreflectivity of inner retinal layers as a quantitative parameter of ischemic damage in acute retinal vein occlusion (RVO): an optical coherence tomography study. Clin Ophthalmol 14:2453–2462. https://doi.org/10.2147/opth.S260000
doi: 10.2147/opth.S260000
pubmed: 32921978
pmcid: 7457850
Mehta N et al (2018) Increased inner retinal layer reflectivity in eyes with acute CRVO correlates with worse visual outcomes at 12 months. Invest Ophthalmol Vis Sci 59:3503–3510. https://doi.org/10.1167/iovs.18-24153
doi: 10.1167/iovs.18-24153
pubmed: 30025093
Ko J, Kwon OW, Byeon SH (2014) Optical coherence tomography predicts visual outcome in acute central retinal vein occlusion. Retina 34:1132–1141. https://doi.org/10.1097/iae.0000000000000054
doi: 10.1097/iae.0000000000000054
pubmed: 24378425
Tsui I, Sarraf D (2013) Paracentral acute middle maculopathy and acute macular neuroretinopathy. Ophthalmic Surg Lasers Imaging Retina 44:33–35. https://doi.org/10.3928/23258160-20131101-06
doi: 10.3928/23258160-20131101-06
Kulikov AN, Maltsev DS, Leongardt TA (2020) Retinal microvasculature alteration in paracentral acute middle maculopathy and acute macular neuroretinopathy: a quantitative optical coherence tomography angiography study. Retin Cases Brief Rep 14:343–351. https://doi.org/10.1097/icb.0000000000000709
doi: 10.1097/icb.0000000000000709
pubmed: 29443808
Nakamura M et al (2019) Longitudinal follow-up of two patients with isolated paracentral acute middle maculopathy. Int Med Case Rep J 12:143–149. https://doi.org/10.2147/imcrj.S196047
doi: 10.2147/imcrj.S196047
pubmed: 31191041
pmcid: 6511651
Zhang Z, Jiang Y, Huang X, Wu Z, Ke B (2021) Clinical characteristics of paracentral acute middle maculopathy in eyes with retinal vascular occlusion diseases in Chinese patients. J Ophthalmol. https://doi.org/10.1155/2021/8867570
doi: 10.1155/2021/8867570
pubmed: 34970453
pmcid: 8714341
Alis A, Guler Alis M (2021) The effect of branch retinal vein occlusion on the vascular structure of the choroid. Photodiagnosis Photodyn Ther 37:102687. https://doi.org/10.1016/j.pdpdt.2021.102687
doi: 10.1016/j.pdpdt.2021.102687
pubmed: 34923154
Hwang BE, Kim M, Park YH (2021) Role of the choroidal vascularity index in branch retinal vein occlusion (BRVO) with macular edema. PLoS ONE 16:e258728. https://doi.org/10.1371/journal.pone.0258728
doi: 10.1371/journal.pone.0258728
pubmed: 34673807
pmcid: 8530297
Tang F et al (2019) Comparison of subfoveal choroidal thickness in eyes with CRVO and BRVO. BMC Ophthalmol 19:133. https://doi.org/10.1186/s12886-019-1143-9
doi: 10.1186/s12886-019-1143-9
pubmed: 31226968
pmcid: 6588881
Rayess N et al (2019) Baseline choroidal thickness as a short-term predictor of visual acuity improvement following antivascular endothelial growth factor therapy in branch retinal vein occlusion. Br J Ophthalmol 103:55–59. https://doi.org/10.1136/bjophthalmol-2018-311898
doi: 10.1136/bjophthalmol-2018-311898
pubmed: 29567791
Sakanishi Y, Morita S, Mashimo K, Tamaki K, Ebihara N (2021) Subfoveal choroidal thickness and treatment outcomes of intravitreal aflibercept for branch retinal vein occlusion. Life (Basel). https://doi.org/10.3390/life11060572
doi: 10.3390/life11060572
Okamoto M, Yamashita M, Sakamoto T, Ogata N (2018) Choroidal blood flow and thickness as predictors for response to anti-vascular endothelial growth factor therapy in macular edema secondary to branch retinal vein occlusion. Retina 38:550–558. https://doi.org/10.1097/iae.0000000000001566
doi: 10.1097/iae.0000000000001566
pubmed: 28234806
Keidel LF et al (2021) Pachychoroid disease and its association with retinal vein occlusion: a case-control study. Sci Rep 11:19854. https://doi.org/10.1038/s41598-021-99115-0
doi: 10.1038/s41598-021-99115-0
pubmed: 34615888
pmcid: 8494827
Adhi M et al (2016) Retinal capillary network and foveal avascular zone in eyes with vein occlusion and fellow eyes analyzed with optical coherence tomography angiography. Invest Ophthalmol Vis Sci 57:OCT486–OCT494. https://doi.org/10.1167/iovs.15-18907
doi: 10.1167/iovs.15-18907
pubmed: 27442342
Coscas F et al (2016) Optical coherence tomography angiography in retinal vein occlusion: evaluation of superficial and deep capillary plexa. Am J Ophthalmol 161:160–171.e1–2. https://doi.org/10.1016/j.ajo.2015.10.008
doi: 10.1016/j.ajo.2015.10.008
pubmed: 26476211
Fan L, Zhu Y, Liao R (2021) Evaluation of macular microvasculature and foveal avascular zone in patients with retinal vein occlusion using optical coherence tomography angiography. Int Ophthalmol. https://doi.org/10.1007/s10792-021-02015-5
doi: 10.1007/s10792-021-02015-5
pubmed: 34739630
pmcid: 8993789
Gadde SG et al (2016) Quantification of vessel density in retinal optical coherence tomography angiography images using local fractal dimension. Invest Ophthalmol Vis Sci 57:246–252. https://doi.org/10.1167/iovs.15-18287
doi: 10.1167/iovs.15-18287
pubmed: 26803800
Kim KM et al (2020) Repeatability of measuring the vessel density in patients with retinal vein occlusion: an optical coherence tomography angiography study. PLoS ONE 15:e234933. https://doi.org/10.1371/journal.pone.0234933
doi: 10.1371/journal.pone.0234933
pubmed: 32584907
pmcid: 7316309
Seknazi D et al (2018) Optical coherence tomography angiography in retinal vein occlusion: correlations between macular vascular density, visual acuity, and peripheral nonperfusion area on fluorescein angiography. Retina 38:1562–1570. https://doi.org/10.1097/iae.0000000000001737
doi: 10.1097/iae.0000000000001737
pubmed: 28574924
Huang J, Lu Y, Gu X, Zheng B, Chen T (2021) Correlation between the nonperfusion area on ultra-widefield fluorescein angiography and nonflow area on optical coherence tomographic angiography in retinal vein occlusion. J Ophthalmol. https://doi.org/10.1155/2021/5581319
doi: 10.1155/2021/5581319
pubmed: 34956672
pmcid: 8709773
Ryu G, Park D, Lim J, van Hemert J, Sagong M (2021) Macular microvascular changes and their correlation with peripheral nonperfusion in branch retinal vein occlusion. Am J Ophthalmol 225:57–68. https://doi.org/10.1016/j.ajo.2020.12.026
doi: 10.1016/j.ajo.2020.12.026
pubmed: 33412121
Yeung L, Wu WC, Chuang LH, Wang NK, Lai CC (2019) Novel optical coherence tomography angiography biomarker in branch retinal vein occlusion macular edema. Retina 39:1906–1916. https://doi.org/10.1097/iae.0000000000002264
doi: 10.1097/iae.0000000000002264
pubmed: 30028408
Shin YI et al (2019) Changes in peripapillary microvasculature and retinal thickness in the fellow eyes of patients with unilateral retinal vein occlusion: an OCTA study. Invest Ophthalmol Vis Sci 60:823–829. https://doi.org/10.1167/iovs.18-26288
doi: 10.1167/iovs.18-26288
pubmed: 30807638
Wakabayashi T et al (2017) Retinal microvasculature and visual acuity in eyes with branch retinal vein occlusion: imaging analysis by optical coherence tomography angiography. Invest Ophthalmol Vis Sci 58:2087–2094. https://doi.org/10.1167/iovs.16-21208
doi: 10.1167/iovs.16-21208
pubmed: 28388705
Winegarner A et al (2018) Retinal microvasculature and visual acuity after intravitreal aflibercept in eyes with central retinal vein occlusion: an optical coherence tomography angiography study. Retina 38:2067–2072. https://doi.org/10.1097/iae.0000000000001828
doi: 10.1097/iae.0000000000001828
pubmed: 28902097
Casselholmde Salles M, Kvanta A, Amrén U, Epstein D (2016) Optical coherence tomography angiography in central retinal vein occlusion: correlation between the foveal avascular zone and visual acuity. Invest Ophthalmol Vis Sci 57:OCT242–OCT246. https://doi.org/10.1167/iovs.15-18819
doi: 10.1167/iovs.15-18819
pubmed: 27409478
Balaratnasingam C et al (2016) Visual acuity is correlated with the area of the foveal avascular zone in diabetic retinopathy and retinal vein occlusion. Ophthalmology 123:2352–2367. https://doi.org/10.1016/j.ophtha.2016.07.008
doi: 10.1016/j.ophtha.2016.07.008
pubmed: 27523615
Suzuki N et al (2016) Retinal hemodynamics seen on optical coherence tomography angiography before and after treatment of retinal vein occlusion. Invest Ophthalmol Vis Sci 57:5681–5687. https://doi.org/10.1167/iovs-16-20648
doi: 10.1167/iovs-16-20648
pubmed: 27784073
Zhu Z et al (2021) Microvascular structure changes after Intravitreal ranibizumab injection in retinal vein occlusion patients with and without macular ischemia. Front Med (Lausanne) 8:737537. https://doi.org/10.3389/fmed.2021.737537
doi: 10.3389/fmed.2021.737537
Hasegawa T, Murakawa S, Maruko I, Kogure-Katakura A, Iida T (2019) Correlation between reduction in macular vessel density and frequency of intravitreal ranibizumab for macular oedema in eyes with branch retinal vein occlusion. Br J Ophthalmol 103:72–77. https://doi.org/10.1136/bjophthalmol-2017-311499
doi: 10.1136/bjophthalmol-2017-311499
pubmed: 29545416
Choi KE, Yun C, Cha J, Kim SW (2019) OCT angiography features associated with macular edema recurrence after intravitreal bevacizumab treatment in branch retinal vein occlusion. Sci Rep 9:14153. https://doi.org/10.1038/s41598-019-50637-8
doi: 10.1038/s41598-019-50637-8
pubmed: 31578437
pmcid: 6775095
Prasad PS, Oliver SC, Coffee RE, Hubschman JP, Schwartz SD (2010) Ultra wide-field angiographic characteristics of branch retinal and hemicentral retinal vein occlusion. Ophthalmology 117:780–784. https://doi.org/10.1016/j.ophtha.2009.09.019
doi: 10.1016/j.ophtha.2009.09.019
pubmed: 20045570
An W, Han J (2021) Research progress of UWFFA and OCTA in retinal vein occlusion: a review. Eur J Ophthalmol 31:2850–2855. https://doi.org/10.1177/11206721211027411
doi: 10.1177/11206721211027411
pubmed: 34798694
Wang X et al (2021) Leakage index on ultra-widefield fluorescence angiography in different regions of retina and its correlation with cystoid macular edema in central retinal vein occlusion eyes. Graefes Arch Clin Exp Ophthalmol 259:2149–2156. https://doi.org/10.1007/s00417-021-05126-y
doi: 10.1007/s00417-021-05126-y
pubmed: 33625562
Nicholson L et al (2021) The clinical relevance of ultra-widefield angiography findings in patients with central retinal vein occlusion and macular oedema receiving anti-VEGF therapy. Eye (Lond). https://doi.org/10.1038/s41433-021-01553-7
doi: 10.1038/s41433-021-01553-7
Tsui I et al (2011) Ischemic index and neovascularization in central retinal vein occlusion. Retina 31:105–110. https://doi.org/10.1097/IAE.0b013e3181e36c6d
doi: 10.1097/IAE.0b013e3181e36c6d
pubmed: 21099454
Thomas AS, Thomas MK, Finn AP, Fekrat S (2019) Use of the ischemic index on widefield fluorescein angiography to characterize a central retinal vein occlusion as ischemic or nonischemic. Retina 39:1033–1038. https://doi.org/10.1097/iae.0000000000002126
doi: 10.1097/iae.0000000000002126
pubmed: 29474305
Campochiaro PA et al (2014) Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study. Ophthalmology 121:209–219. https://doi.org/10.1016/j.ophtha.2013.08.038
doi: 10.1016/j.ophtha.2013.08.038
pubmed: 24112944